Huntington Beach, CALIFORNIA2 Active Studies

Atrial Fibrillation Clinical Trials in Huntington Beach, CALIFORNIA

Find 2 actively recruiting atrial fibrillation clinical trials in Huntington Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,901
Enrolling

Recruiting Atrial Fibrillation Studies in Huntington Beach

About Atrial Fibrillation Clinical Trials in Huntington Beach

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 2 atrial fibrillation clinical trials recruiting participants in Huntington Beach, CALIFORNIA. These studies are seeking a combined 1,901 participants. Research is being sponsored by Anthos Therapeutics, Inc., Regenerative Ocular Immunobiologics LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Huntington Beach — FAQ

Are there atrial fibrillation clinical trials in Huntington Beach?

Yes, there are 2 atrial fibrillation clinical trials currently recruiting in Huntington Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Huntington Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntington Beach research site will contact you about next steps.

Are clinical trials in Huntington Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntington Beach studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 2 active trials in Huntington Beach are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated March 2, 2026 from ClinicalTrials.gov